Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
Melanoma is the most aggressive skin cancer and its incidence is gradually increasing worldwide. Patients with metastatic melanoma have a very poor prognosis (estimated 5-year survival rate of <16%). In the last few years, several drugs have been approved for malignant melanoma, such as tyrosine...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Association of Immunologists
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411510/ |